Craig M. McDonald researcher
McDonald, Craig M.
VIAF ID: 296109236 (Personal)
Permalink: http://viaf.org/viaf/296109236
Preferred Forms
- 100 0 _ ‡a Craig M. McDonald ‡c researcher
- 100 1 _ ‡a McDonald, Craig M.
- 100 1 _ ‡a McDonald, Craig M.
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations | |
Ambulatory Outcome of Children with Myelomeningocele: Effect of Lower-Extremity Muscle Strength | |
Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy | |
Challenges in drug development for muscle disease: a stakeholders' meeting. | |
Change in life satisfaction of adults with pediatric-onset spinal cord injury. | |
A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial. | |
The Child with a High Tetraplegic Spinal Cord Injury | |
Chronic pain in persons with neuromuscular disease | |
Classification of the gait patterns of boys with Duchenne muscular dystrophy and their relationship to function | |
Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases | |
Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45. | |
Comparison of indices of traumatic brain injury severity as predictors of neurobehavioral outcome in children. | |
Convexity of scoliosis related to handedness in identical twin boys with Duchenne's muscular dystrophy: a case report | |
The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing an | |
Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial | |
Developing standardized corticosteroid treatment for Duchenne muscular dystrophy. | |
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care | |
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study | |
Evaluation of phrenic nerve and diaphragm function with peripheral nerve stimulation and M-mode ultrasonography in potential pediatric phrenic nerve or diaphragm pacing candidates | |
Health and fitness in pediatric spinal cord injury: medical issues and the role of exercise | |
Hip kinetics during gait are clinically meaningful outcomes in young boys with Duchenne muscular dystrophy | |
How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration | |
ICU-Acquired Weakness Is Associated With Differences in Clinical Outcomes in Critically Ill Children | |
Isolated femoral mononeuropathy to the vastus lateralis: EMG and MRI findings | |
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy | |
LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy | |
Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy | |
Mexiletine for muscle cramps in amyotrophic lateral sclerosis: A randomized, double-blind crossover trial. | |
Mobility-assistive technology in progressive neuromuscular disease | |
Modifications to the Traditional Description of Neurosegmental Innervation in Myelomeningocele | |
A multinational study on motor function in early-onset FSHD | |
Natural history of infantile-onset spinal muscular atrophy. | |
Neuromuscular disease management and rehabilitation. Part II, c2012: | |
New clinical end points in rehabilitation medicine: tools for measuring quality of life | |
Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene | |
Pain in Myotonic Muscular Dystrophy, Type 1 | |
Pain in persons with postpolio syndrome: frequency, intensity, and impact | |
Pediatric Spinal Cord Injury: Evidence-Based Practice and Outcomes | |
Physical activity, health impairments, and disability in neuromuscular disease | |
Placebo-controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy | |
Prednisone and Deflazacort in Duchenne Muscular Dystrophy: Do They Play a Different Role in Child Behavior and Perceived Quality of Life? | |
Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study | |
Presynaptic congenital myasthenic syndrome with a homozygous sequence variant in LAMA5 combines myopia, facial tics, and failure of neuromuscular transmission. | |
Reachable workspace and performance of upper limb (PUL) in duchenne muscular dystrophy | |
Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA! | |
Regional and whole-body dual-energy X-ray absorptiometry to guide treatment and monitor disease progression in neuromuscular disease | |
Relationship between clinical outcome measures and parent proxy reports of health-related quality of life in ambulatory children with Duchenne muscular dystrophy | |
The relationship between regional body composition and quantitative strength in facioscapulohumeral muscular dystrophy (FSHD). | |
Reliability of radiographic parameters in neuromuscular scoliosis | |
The role of the neuromuscular medicine and physiatry specialists in the multidisciplinary management of neuromuscular disease | |
Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children | |
Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy | |
Treatment of spine deformity in neuromuscular diseases | |
Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy | |
Utility of a step activity monitor for the measurement of daily ambulatory activity in children | |
The validity of compliance monitors to assess wearing time of thoracic-lumbar-sacral orthoses in children with spinal cord injury. | |
Variable phenotypes associated with mutations in DOK7. | |
Why short stature is beneficial in Duchenne muscular dystrophy |